- Report
- September 2025
- 120 Pages
Middle East
From €5254EUR$5,950USD£4,538GBP
- Report
- September 2025
- 120 Pages
United States
From €5254EUR$5,950USD£4,538GBP
- Report
- July 2025
- 250 Pages
North America
From €3417EUR$3,869USD£2,951GBP
- Report
- February 2026
- 230 Pages
United States
From €4283EUR$4,850USD£3,699GBP
- Report
- February 2026
- 150 Pages
United States
From €4283EUR$4,850USD£3,699GBP
- Report
- February 2026
- 150 Pages
United States
From €4283EUR$4,850USD£3,699GBP
- Report
- July 2025
- 224 Pages
Europe
From €3047EUR$3,450USD£2,631GBP
- Report
- January 2026
- 110 Pages
United States
From €1351EUR$1,530USD£1,167GBP
€1589EUR$1,800USD£1,373GBP
- Report
- October 2025
- 84 Pages
United States
From €4283EUR$4,850USD£3,699GBP
- Report
- October 2025
- 90 Pages
Asia Pacific
From €4283EUR$4,850USD£3,699GBP
- Training
- October 2025
- 2 Days
United States
From €1349EUR$1,528USD£1,165GBP
€1587EUR$1,798USD£1,371GBP
From €4283EUR$4,850USD£3,699GBP
From €4283EUR$4,850USD£3,699GBP
- Report
- October 2025
- 100 Pages
Asia Pacific
From €4283EUR$4,850USD£3,699GBP
- Report
- May 2025
- 83 Pages
Middle East, Africa
From €2605EUR$2,950USD£2,250GBP
- Report
- May 2025
- 98 Pages
Asia Pacific
From €3047EUR$3,450USD£2,631GBP
- Report
- May 2025
- 102 Pages
Europe
From €3047EUR$3,450USD£2,631GBP
- Report
- May 2025
- 91 Pages
North America
From €2605EUR$2,950USD£2,250GBP
- Report
- April 2025
- 285 Pages
Global
From €5212EUR$6,109USD£4,350GBP
- Report
- September 2018
- 200 Pages
Global
From €3090EUR$3,499USD£2,669GBP

The Pharmaceutical Regulation market is a sector of the pharmaceutical industry that focuses on the regulation of drugs and other related products. It is responsible for ensuring that drugs are safe and effective for use by the public. This includes the evaluation of clinical trials, the approval of new drugs, and the monitoring of drug safety and efficacy. The market also includes the enforcement of regulations and the enforcement of intellectual property rights.
The Pharmaceutical Regulation market is composed of a variety of stakeholders, including pharmaceutical companies, regulatory authorities, and research institutions. Pharmaceutical companies are responsible for the development and production of drugs, while regulatory authorities are responsible for the approval and monitoring of drugs. Research institutions are responsible for conducting clinical trials and providing data to regulatory authorities.
Some of the major companies in the Pharmaceutical Regulation market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more